Serina Therapeutics, Inc. (SER)
NYSEAMERICAN: SER · Real-Time Price · USD
2.420
-0.150 (-5.84%)
Sep 10, 2026, 11:32 AM EDT - Market open
Serina Therapeutics Market Cap
Serina Therapeutics has a market cap or net worth of $61.47 million as of September 10, 2026. Its market cap has increased by 11.88% in one year.
Market Cap
61.47M
Enterprise Value
42.20M
1-Year Change
11.88%
Ranking
Category
Stock Price
$2.42
ChartMarket Cap Chart
Since March 27, 2024, Serina Therapeutics's market cap has decreased from $125.13M to $61.47M, a decrease of -50.87%. That is a compound annual growth rate of -25.12%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 10, 2026 | 61.47M | 201.31% |
| Dec 31, 2025 | 20.40M | -56.64% |
| Dec 31, 2024 | 47.05M | -62.40% |
| Mar 27, 2024 | 125.13M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cingulate | 74.16M |
| Nutriband | 72.57M |
| Champions Oncology | 72.52M |
| Pliant Therapeutics | 71.83M |
| LeonaBio | 71.23M |
| Spero Therapeutics | 70.46M |
| INmune Bio | 67.72M |
| XBiotech | 67.07M |